Gotto, G., D. E. Drachenberg, J. Chin, R. Casey, V. Fradet, R. Sabbagh, B. Shayegan, R. A. Rendon, B. Danielson, F. Camacho, A. Zardan, R. Plante, H. Hew, K. Chan, and A. Feifer. “Real-World Evidence in Patient-Reported Outcomes (PROs) of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Patients Treated With Abiraterone Acetate + Prednisone (AA+P) across Canada: Final Results of COSMiC”. Canadian Urological Association Journal, vol. 14, no. 12, June 2020, pp. E616-20, doi:10.5489/cuaj.6388.